When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 167 Hits
  • Search Condition : Filter (MeSH = Protein Kinase Inhibitors / pharmacology)
Species Resource Title
Human and Animal Cells RBE(RCB1292) JNK inhibitor SP600125 enhances TGF-β-induced apoptosis of RBE human cholangiocarcinoma cells in a Smad-dependent manner.
Human and Animal Cells iPS-MEF-Ng-20D-17(APS0001) Stimulation of 5-HT4 receptor enhances differentiation of mouse induced pluripotent stem cells into neural progenitor cells.
Human and Animal Cells KGN(RCB1154) Effect of epidermal growth factor and prostaglandin on the expression of aromatase (CYP19) in human adrenocortical carcinoma cell line NCI-H295R cells.
Human and Animal Cells MMAc·SF(RCB1200) AP-1 transcription factor network explains diverse patterns of cellular plasticity in melanoma cells.
Human and Animal Cells HCE-T(RCB2280) High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibition.
Human and Animal Cells 293(RCB1637) , G-361(RCB0991) , A549(RCB3677) , T24(RCB2536) , A431(RCB0202) , PANC-1(RCB2095) , HCT116(RCB2979) , 293gp(RCB2354) Qualitative differences in disease-associated MEK mutants reveal molecular signatures and aberrant signaling-crosstalk in cancer.
Human and Animal Cells Ba/F3(RCB0805) , WEHI-3(RCB0035) Foretinib can overcome common on-target resistance mutations after capmatinib/tepotinib treatment in NSCLCs with MET exon 14 skipping mutation.
Human and Animal Cells HeLa.S3(RCB0191) Various effects of two types of kinesin-5 inhibitors on mitosis and cell proliferation.
Human and Animal Cells Ba/F3(RCB0805) Analysis of lorlatinib analogs reveals a roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer.
Human and Animal Cells Ba/F3(RCB0805) Utility of the Ba/F3 cell system for exploring on-target mechanisms of resistance to targeted therapies for lung cancer.
Human and Animal Cells iPS-MEF-Ng-20D-17(APS0001) , PK-8(RCB2700) The significance of ErbB2/3 in the conversion of induced pluripotent stem cells into cancer stem cells.
Human and Animal Cells PC-9(RCB4455) Heterogeneity among tumors with acquired resistance to EGFR tyrosine kinase inhibitors harboring EGFR-T790M mutation in non-small cell lung cancer cells.
Human and Animal Cells HSC-2(RCB1945) , HSC-3(RCB1975) , HSC-4(RCB1902) , SAS(RCB1974) Epidermal growth factor/epidermal growth factor receptor signaling blockage inhibits tumor cell-derived exosome uptake by oral squamous cell carcinoma through macropinocytosis.
Human and Animal Cells MCF7(RCB1904) ErbB4-mediated regulation of vasculogenic mimicry capability in breast cancer cells.
Human and Animal Cells A549 , RERF-LC-AI(RCB0444) , RERF-LC-KJ(RCB1313) Tofacitinib overcomes an IFNγ-induced decrease in NK cell-mediated cytotoxicity via the regulation of immune-related molecules in LC-2/ad.
Human and Animal Cells A549(RCB0098) , LC-2/ad(RCB0440) , RERF-LC-KJ(RCB1313) MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells.
Human and Animal Cells Ba/F3(RCB0805) , PC-9(RCB4455) TAS6417, A Novel EGFR Inhibitor Targeting Exon 20 Insertion Mutations.
Human and Animal Cells T98G(RCB1954) Targeting JNK for therapeutic depletion of stem-like glioblastoma cells.
Human and Animal Cells WI-38(RCB0702) Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-beta1.
Human and Animal Cells K562(RCB1897) KIR3DL1 Allotype-Dependent Modulation of NK Cell Immunity against Chronic Myeloid Leukemia.